SECOND EXTENSION - GRANTED
granted
on 30 Jul 2024
Last Applicant/ Owned by
12 Michigan Drive
Natick
MA
01760
Serial Number
97225171 filed on 18th Jan 2022
Registration Number
N/A
Correspondent Address
Andrew T. Pettit
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
MRDTECT
Software as a service (SaaS), namely, hosting non-downloadable software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, diagnostic research, and diagnostics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of diagnostics; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services for medical purposes, health and wellness assessment services; providing health and wellness information; medical services, namely, diagnostic testing for the presence of cancer molecules in bodily fluids; diagnostic testing relating to human health; medical testing services relating to the diagnosis, treatment, and recurrence monitoring of disease; management services, namely, management of medical information derived through nucleic acid sequencing, including next-generation sequencing (NGS), and information gathered through analysis of the medical information
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Software as a service (SaaS), namely, hosting non-downloadable software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, diagnostic research, and diagnostics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable software for use by others with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids, , genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; software as a service (SaaS), namely, hosting non-downloadable software for health and wellness assessment, namely, for genomic analysis; software as a service (SaaS), namely, hosting non-downloadable software for genetic and bioinformatics analysis; bioinformatics services, namely, product research and development in the field of bioinformatics; data processing services for medical, clinical, and scientific purposes; developing diagnostic testing models for others for medical, clinical, and scientific purposes; genetic testing for scientific research purposes; scientific consulting relating to scientific research; scientific services, namely, detection and analysis of cancer molecules in bodily fluids; scientific, clinical, and diagnostic research in the field of bioinformatics; scientific, clinical, and diagnostic research in the fields of disease detection and management; scientific, clinical, and diagnostic research in the fields of cancer discovery, cancer management, therapy efficacy, and recurrence monitoring
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [035]
Advertising, Business & Retail Services
Data processing services for medical, clinical, and scientific purposes; data processing services, namely, analysis of sequencing data to detect the presence and prevalence of cancer molecules; management services, namely, management of business information insights learned through analysis of the information relating to preventative medicine marketability
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Downloadable software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, diagnostic research, and diagnostics; downloadable software for analyzing biological samples; downloadable software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; downloadable software for use with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; downloadable software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; downloadable software for health and wellness assessment, namely, for use in genomic analysis; downloadable software for genetic and bioinformatics analysis; downloadable software for testing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules for research purposes; downloadable software for testing DNA and RNA molecules for diagnostic purposes; downloadable software, namely, data analysis software for use in the fields of nucleic acid sequencing, genotyping, scientific research, clinical research, diagnostics research, and diagnostics; downloadable software for bioinformatics analysis of information derived through next generation sequencing (NGS); downloadable software for discovering and tracking indicators of disease through analysis of sequencing data; downloadable software for detecting the presence and prevalence of cancer molecules through analysis of sequencing data; universal serial bus (USB) flash drives, memory cards, and solid state drives with software installed thereon, namely, software for genetic and bioinformatics analysis; electronic devices, namely, tablet computers, desktop computers, and mobile workstations, with software installed thereon, namely, software for genetic and bioinformatics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being used for medical and veterinary purposes; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for medical and veterinary purposes; biological and biochemical kits for medical and veterinary diagnostic purposes; reagents, assays, enzymes, nucleotides, buffers, and chemical and biological preparations for diagnostic purposes; reagents and reagent kits for amplifying, analyzing, labeling, and detecting nucleic acids for medical and veterinary purposes; reagents and reagent kits for monitoring the efficacy of therapies through analysis of bodily fluids for medical and veterinary purposes; reagents and reagent kits for determining the presence of diseases through analysis of bodily fluids for medical and veterinary purposes; reagents and reagent kits for monitoring therapeutic response and the recurrence of diseases through analysis of bodily fluids for medical and veterinary purposes; reagents and reagent kits detecting cancer molecules in bodily fluids for medical and veterinary purposes; diagnostic substances for medical and veterinary use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and diagnostic research; biological and biochemical reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for selectively amplifying nucleic acid fragments for scientific research, clinical research, and diagnostic research; biological and biochemical kits for scientific research, clinical research, and diagnostic research; reagents, assays, enzymes, nucleotides, buffers, and chemical and biological preparations for diagnostic purposes; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with amplifying, analyzing, labeling, and detecting nucleic acids; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with monitoring the efficacy of therapies through analysis of bodily fluids; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with determining the presence of diseases through analysis of bodily fluids; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with monitoring therapeutic response and the recurrence of diseases through analysis of bodily fluids; reagents and reagent kits comprising nucleic acids, naturally occurring nucleotides, modified nucleotides, enzymes, and buffers, for scientific, clinical, and research use in connection with detecting cancer molecules in bodily fluids
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97225171
Mark Type
No Service Mark
Attorney Docket Number
No 113970-4012
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Jul 2024 | SOU EXTENSION 2 FILED |
| 30th Jul 2024 | SOU EXTENSION 2 GRANTED |
| 30th Jul 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 30th Jul 2024 | SOU TEAS EXTENSION RECEIVED |
| 03rd Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 01st Feb 2024 | SOU EXTENSION 1 GRANTED |
| 01st Feb 2024 | SOU EXTENSION 1 FILED |
| 01st Feb 2024 | SOU TEAS EXTENSION RECEIVED |
| 08th Aug 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 13th Jun 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |